Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 0.0 | BCD100322A02 | 2.45 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 0.5 | BCD100322A05 | 1.87 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 1.0 | BCD100322A09 | 2.37 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 2.0 | BCD100322A13 | 2.22 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 4.0 | BCD100322A17 | 2.14 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 8.0 | BCD100322A21 | 1.9 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 12.0 | BCD100322A25 | 1.33 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | Lipid-depleted/compactin | 24.0 | BCD100322A29 | 1.97 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 0.0 | BCD100322A01 | 5.42 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 0.5 | BCD100322A03 | 7.34 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 1.0 | BCD100322A07 | 7.24 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 2.0 | BCD100322A11 | 8.08 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 4.0 | BCD100322A15 | 7.25 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 8.0 | BCD100322A19 | 7.26 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 12.0 | BCD100322A23 | 7.35 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | C | 24.0 | BCD100322A27 | 5.39 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A06 | 1.69 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A10 | 2.58 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A14 | 1.66 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A18 | 2.37 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A22 | 2.18 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A26 | 1.48 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A30 | 2.59 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 0.5 | BCD100322A04 | 7.41 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 1.0 | BCD100322A08 | 8.95 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 2.0 | BCD100322A12 | 8.19 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 4.0 | BCD100322A16 | 6.44 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 8.0 | BCD100322A20 | 6.53 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 12.0 | BCD100322A24 | 7.43 | pmol/sample |
| LMFA03010051 | 15-deoxy-δ-12,14-PGD2 | 25OH-Chol | 24.0 | BCD100322A28 | 4.98 | pmol/sample |